TARDBP and amyotrophic lateral sclerosis: Therein, we showed that viral delivery of a single-chain antibody against the RRM1 domain of TDP43 was able to recognize its target and to reduce the levels of cytoplasmic TDP43 accumulation, together with improvement of cognitive and motor functions in 2 mouse models of ALS/FTLD (22).